Table 2.
Clinical and demographical data of cohort 2.
| RoPE 0–5 (n = 14) | RoPE 6–10 (n = 24) | P -value | |
|---|---|---|---|
| Age (years) | 55 (53–60) | 48 (40–54) | < 0.001 |
| Sex (female) | 4 (29%) | 11 (46%) | 0.329 |
| Arterial hypertension | 9 (64%) | 5 (21%) | 0.014 |
| Diabetes | 2 (14%) | 1 (4%) | 0.542 |
| Adiposity | 6 (43%) | 5 (21%) | 0.266 |
| Dyslipoproteinemia | 7 (50%) | 10 (42%) | 0.740 |
| Peripheral artery disease | 0 (0%) | 0 (0%) | 0.999 |
| Nicotine consumption | 10 (71%) | 16 (67%) | 0.999 |
| Alcohol consumption | 1 (7%) | 2 (8%) | 0.999 |
| Coronary artery disease | 0 (0%) | 0 (0%) | 0.999 |
| Angina pectoris | 0 (0%) | 0 (0%) | 0.999 |
| Myocardial infarction | 0 (0%) | 0 (0%) | 0.999 |
| Atrial fibrillation | 0 (0%) | 0 (0%) | 0.999 |
| Pos. Family history | 3 (21%) | 7 (29%) | 0.715 |
| NIHSS at enrollment | 0 (0–1.5) | 0 (0–0) | 0.161 |
| mRS at enrollment | 0 (0–1) | 0 (0–0.75) | 0.800 |
| BMI (kg/m2) | 27 (24–34) | 25 (25–28) | 0.212 |
| CHA2DS2VASC | 3.00 (2.75–4.00) | 3.00 (2.00–3.00) | 0.135 |
| ESRS | 2 (1,2) | 1 (0.25–1) | 0.003 |
| Time from index event to follow-up (days) | 98 (52–144) | 115 (65–202) | 0.560 |
Continuous data are presented as median (quartile 1–quartile 3).